Insider Transactions in Q1 2024 at Idexx Laboratories Inc (IDXX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 06
2024
|
James F Polewaczyk Executive Vice President |
SELL
Open market or private sale
|
Direct |
8,104
-16.78%
|
$4,522,032
$558.72 P/Share
|
|
Mar 06
2024
|
James F Polewaczyk Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
8,104
+10.85%
|
$2,520,344
$311.69 P/Share
|
|
Mar 05
2024
|
Sophie V. Vandebroek Director |
SELL
Open market or private sale
|
Direct |
1,404
-53.59%
|
$789,048
$562.98 P/Share
|
|
Mar 05
2024
|
Sophie V. Vandebroek Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,404
+34.89%
|
$343,980
$245.79 P/Share
|
|
Feb 29
2024
|
Jonathan Jay Mazelsky President and CEO |
SELL
Bona fide gift
|
Direct |
550
-0.67%
|
-
|
|
Feb 21
2024
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
483
+0.59%
|
$99,498
$206.94 P/Share
|
|
Feb 16
2024
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
483
+7.95%
|
$99,498
$206.94 P/Share
|
|
Feb 15
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
483
+1.54%
|
$99,498
$206.94 P/Share
|
|
Feb 14
2024
|
Michael G Erickson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
144
-1.33%
|
$80,640
$560.56 P/Share
|
|
Feb 14
2024
|
Michael G Erickson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
462
+0.86%
|
-
|
|
Feb 14
2024
|
George Fennell SVP, Chief Revenue Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-2.29%
|
$90,720
$560.56 P/Share
|
|
Feb 14
2024
|
George Fennell SVP, Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
370
+1.05%
|
-
|
|
Feb 14
2024
|
Nimrata Hunt Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
263
-2.2%
|
$147,280
$560.56 P/Share
|
|
Feb 14
2024
|
Nimrata Hunt Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
208
+1.71%
|
-
|
|
Feb 14
2024
|
Nimrata Hunt Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
664
+1.42%
|
-
|
|
Feb 14
2024
|
Michael Perkins Johnson EVP and CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
60
-24.69%
|
$33,600
$560.56 P/Share
|
|
Feb 14
2024
|
Michael Perkins Johnson EVP and CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
176
+42.0%
|
-
|
|
Feb 14
2024
|
Michael Lane Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
283
-4.21%
|
$158,480
$560.56 P/Share
|
|
Feb 14
2024
|
Michael Lane Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
939
+2.88%
|
-
|
|
Feb 14
2024
|
Jonathan Jay Mazelsky President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,839
-2.21%
|
$1,029,840
$560.56 P/Share
|
|
Feb 14
2024
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,156
+1.01%
|
-
|
|
Feb 14
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,097
-3.49%
|
$614,320
$560.56 P/Share
|
|
Feb 14
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,731
+1.11%
|
-
|
|
Feb 14
2024
|
James F Polewaczyk Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
279
-2.54%
|
$156,240
$560.56 P/Share
|
|
Feb 14
2024
|
James F Polewaczyk Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
927
+1.72%
|
-
|
|
Feb 14
2024
|
Michael Schreck Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
117
-12.96%
|
$65,520
$560.56 P/Share
|
|
Feb 14
2024
|
Michael Schreck Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
368
+13.74%
|
-
|
|
Feb 14
2024
|
Martin Alexander Smith Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
108
-18.56%
|
$60,480
$560.56 P/Share
|
|
Feb 14
2024
|
Martin Alexander Smith Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
337
+25.94%
|
-
|
|
Feb 14
2024
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-6.51%
|
$199,360
$560.56 P/Share
|
|
Feb 14
2024
|
Sharon E. Underberg EVP, GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,186
+4.45%
|
-
|
|
Feb 09
2024
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
5,350
-1.98%
|
-
|
|
Feb 08
2024
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
850
-0.31%
|
-
|
|
Feb 08
2024
|
George Fennell SVP, Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
8,198
-14.24%
|
$4,697,454
$573.94 P/Share
|
|
Feb 08
2024
|
George Fennell SVP, Chief Revenue Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,810
+27.42%
|
$608,220
$62.0 P/Share
|
|
Feb 07
2024
|
Jonathan Jay Mazelsky President and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-2.76%
|
$6,876,000
$573.53 P/Share
|
|
Feb 07
2024
|
Jonathan Jay Mazelsky President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+11.62%
|
$804,000
$67.85 P/Share
|
|
Feb 07
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
23,326
-6.04%
|
$13,249,168
$568.56 P/Share
|
|
Feb 07
2024
|
Brian P Mckeon EVP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,326
+30.54%
|
$3,288,966
$141.6 P/Share
|
|
Feb 07
2024
|
Jonathan W Ayers Director |
SELL
Bona fide gift
|
Direct |
1,000
-0.37%
|
-
|
|
Jan 30
2024
|
Daniel M Junius Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.46%
|
$7,294
$521.03 P/Share
|